CTRI/2018/05/013934
Recruiting
未知
Retrospective observational study to evaluate therapeutic efficacy of Herbometallic Ayur-vedic compounds in the management of patients with chronic kidney disease (CKD) with respect to improvement in renal functions
Rasayani Cancer Clinics Pune0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Rasayani Cancer Clinics Pune
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Primary diagnosis of Chronic Renal Failure with Serum creatinine \>1\.5 mg/dL
- •Elevated Cystantin C level
- •Patients taking or has taken Ayurved therapy for treatment of Chronic Renal Failure
- •Patients taking or has taken Ayurved therapies for a minimum period of 3 months
Exclusion Criteria
- •1\. Patients taking or has taken injection of erythropoietin.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Study of patients with chronic renal failure treated with Ayurveda medicines to evaluate the efficacy of Ayurveda compounds in treating patients of Chronic renal failureCTRI/2018/05/014297Ayurved Clinic50
Not yet recruiting
Not Applicable
A retrospective observational study to evaluate the efficacy of terminal warm blood cardioplegia with the microplegia method in cardiac surgery.cardiac surgeryJPRN-UMIN000046836The Jikei university school of medicine60
Not yet recruiting
Not Applicable
To study how much blood is used from the blood bank for children during surgery at a tertiary care cancer institute in India.CTRI/2022/12/048160Tata Memorial Hospital
Not yet recruiting
Not Applicable
To identify the particular reason in occurence of Rheumatoid Arthritis disease.CTRI/2024/05/067785Sanjeevini Ayurveda Medical College and Hospital
Active, not recruiting
Not Applicable
A retrospective, observational study to evaluate the effectiveness of Carnitine complex (GODEX®) in patients with nonalcoholic fatty liver disease.KCT0003058Celltrion Pharm30